Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)|March 21, 2022
[Lessons learned in the Covid-19 pandemic: Novel approaches to respiratory disease prevention]Sol Minoldo, Javier Farina, Rodrigo Quiroga
Medicina|January 30, 2019
[Central venous catheter related infections. Inter-Societies update and recommendations]Javier Farina, Wanda Cornistein, Carina Balasini, et al.
Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia|August 28, 2020
[Candidemia: characteristics in elderly patients]Natalia A Díaz, Javier Farina, Jorge Herrera, et al.
Plos One|April 30, 2021
Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower respiratory tract infections in ArgentinaOsvaldo Ulises Garay, Gonzalo Guiñazú, Wanda Cornistein, et al.
Medicina|August 22, 2024
[Molecular diagnosis of bacteriaemia: benefits of using the FilmArray® BCID2 sepsis panel in a third level hospital]Natalia A Díaz, Javier Farina, Liucó Zubeldía Brenner, et al.
Medicina|May 23, 2020
[Argentine Intersociety Consensus on Urinary Infection 2018-2019 - Part II]Corina Nemirovsky, María José López Furst, Daniel Pryluka, et al.
Eclinicalmedicine|June 30, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trialAlejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Eclinicalmedicine|August 31, 2021
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]"Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Open Forum Infectious Diseases|April 13, 2026
Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort StudyEzequiel Cordova, Juan Pablo Balbuena, Analia Mykietiuk, et al.
Eclinicalmedicine|April 19, 2021
RBD-specific polyclonal F(ab´)<sub>2</sub> fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trialGustavo Lopardo, Waldo H Belloso, Esteban Nannini, et al.
Pageof 2